CD274 and cholangiocarcinoma: The results obtained in these studies are highly heterogeneous, ranging from 4 -100% PD-L1 positive cases in iCCA, and 8 -  43% PD-L1 positive cases in extrahepatic CCA, including pCCA and dCCA.